Press Releases

Lonza has announced an agreement for the supply of TiGenix's eASC product, Cx601. Under the agreement, Lonza will manufacture material for the Phase III trial of Cx601 in the US at Lonza's cell therapy production facility in Walkersville, Maryland....

Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement. VTU Technology, currently offering a very broad and versatile technology...

TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, today reports its revenues as of December 31, 2014 and updates on forthcoming milestones. ...

Dr. Parvinder Punia, Senior regulatory expert will present “European experience of harmonising the pharmaceutical market” at Moscow conference on February 10th 2015 Cambridge, UK, 2nd February 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs, today...

Cosmofarma Exhibition 2015, the leading event for the pharmacy world organized by Bologna Fiere and held in Bologna from 17 to 19 April, offers companies the most functional business opportunities with major national and international distributors. To encourage networking...

80% of the finalists for the ‘Most Valuable Patient Initiative’ Categoryof the 2015 eyeforpharma Philadelphia Awards are focussing on education as a means of engaging with andimproving the lives of patients. Projects from Novartis and...

eyeforpharma, London (January, 19, 2015): According to LEO Pharma, Ipsen and Grünenthaldriving patient-centric leadership has become priority as the patient voice shapes the future for the pharmaceutical industry. Speaking ahead...